Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New and Old Key Players in Liver Cancer
Ángel M. Cuesta, Nerea Palao, Paloma Bragado, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17152-17152
Open Access | Times Cited: 11

Showing 11 citing articles:

Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 18
Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
Felix Fiehn, Claudia Beisel, Marco Binder
Current Opinion in Virology (2024) Vol. 67, pp. 101423-101423
Open Access | Times Cited: 9
New Hepatocellular Carcinoma (HCC) Primary Cell Cultures as Models for Exploring Personalized Anti-TGF-β Therapies Based on Tumor Characteristics
Rosanna Scialpi, Rut Espinosa‐Sotelo, Esther Bertrán, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2430-2430
Open Access
Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression
Roohi Chaudhary, Ralf Weiskirchen, Marcelo Ehrlich, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response
Cristina Baquero, Minerva Iniesta‐González, Nerea Palao, et al.
The Journal of Pathology (2025) Vol. 265, Iss. 4, pp. 502-517
Open Access
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives
Valeria De Gaetano, Maria Pallozzi, Lucia Cerrito, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1388-1388
Open Access | Times Cited: 3
MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFβ pathway
Rong Ke, Navin Viswakarma, Mary Menhart, et al.
Oncogene (2024)
Closed Access | Times Cited: 3
Aspirin suppresses hepatocellular carcinoma progression by inhibiting platelet activity
Lijun Zhao, Zhiyin Wang, Wei-Ting Liu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 6, pp. 2742-2756
Open Access | Times Cited: 2
Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies
Yusra Zarlashat, Hafiz Salman Mushtaq, Linh Pham, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6830-6830
Open Access | Times Cited: 2
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives
Federica Rapetti, Andrea Spallarossa, Eleonora Russo, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2298-2298
Open Access | Times Cited: 1
A Comprehensive Review on Molecular Mechanisms, Treatments, and Brief Role of Natural Products in Hepatocellular Cancer
Linlin Jiang, Qin Meng, Lixiu Liu, et al.
Natural Product Communications (2024) Vol. 19, Iss. 9
Open Access
Endosomal disruption by co-encapsulating gentamicin in lipid nanoparticles for efficient siRNA delivery and cancer therapy
Ning Yang, Qi Sun, Yaoqi Wang, et al.
Asian Journal of Pharmaceutical Sciences (2024), pp. 101011-101011
Open Access
Page 1

Scroll to top